News
Key Patent Cases to Watch in 2025
Insights from Partner, Joseph J. Weissman
Intellectual Property and Litigation Attorney
The landscape of U.S. patent law is set for pivotal changes in 2025, with several high-profile cases under review. Among them, Edwards Lifesciences Corp. v. Meril Life Sciences Pvt. Ltd. stands out. This case, currently being reviewed by the U.S. Supreme Court, examines the research and development safe harbor’s application to the importation of medical devices for non-commercial use—critical for the future of patent law.
Joseph J. Weissman, Partner at Johnson Pope, provided key insights into the case:
“It could have a pretty large impact on how foreign companies treat patent law within the United States in terms of importing their not-yet-approved health products.”
This case could shape how medical device companies approach FDA approvals and clinical trials in the U.S., making it a critical issue for patent law practitioners and innovators in the medical field.
Learn more about Joseph J. Weissman and his expertise in intellectual property by visiting his profile.